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The respective institutional review boards and ethics committees of Shinseikai Toyama Hospital (Permit Number: 150503) and Komoro Kosei General Hospital (Permit Number: 2705) approved this study, which was conducted in accordance with the tenets of the 1995 Declaration of Helsinki (as revised in Edinburgh, 2000) .
Informed consent was obtained from all participants.
Participants were divided into four groups based on the presence of glaucoma and/or short BUT (≤ 5 seconds); non-glaucoma with normal BUT as control group, non-glaucoma with short BUT group, glaucoma without short BUT group, and glaucoma with short BUT group.
2.2.Inclusion and exclusion criteria
Patients were enrolled if they had their IOP measured during four consecutive seasons and received the same medication during the study period. Study participants visited our clinic for regular checkups for early cataract, eye fatigue, DED, and glaucoma. Patients were excluded from the study if they had visual impairment (< 20/25 in either eye) or were under 20 years of age. Patients were excluded from the study if they had history of past glaucoma surgery, or any ocular surgery within twelve months. We excluded patients from glaucoma cases if they have secondary glaucoma, uveitis, or steroid administration.
2.3.Ophthalmological examinations
IOP was measured in the morning session between 8 am and 12 midday, using a non-contact tonometer in all cases. The mean BUT and corneal staining scores (0-9 points) were based on the Japanese dry eye diagnostic criteria, [23] with BUT evaluated three times, and the mean value determined. Corneal fluorescein staining scores were evaluated in three areas and scored on a 0-to 2-point scale (0: no damage to 2: damaged entirely); the scores were summed up to a maximum of 2 points in total. Ocular surface abnormality was defined as a BUT ≤ 5 seconds and corneal staining scores ≥ 1 point based on previous studies. [24, 25] . The BUT and corneal fluorescein staining score were determined at the date of each patient's visit in year 2017 and classified as follows: spring from March to May, summer from June to August, fall from September to November, and winter from December to February.
All glaucoma cases were bilateral open angle glaucoma or normal tension glaucoma. For glaucoma diagnosis, we conducted a visual field test (Humphrey Visual Field Analyzer 30-2 standard program; Carl Zeiss, Jena, Germany), measuring the thickness of ganglion cell complexes using optical coherent tomography (OCT; RC3000R (Nidek, Gamagori, Japan) and Cirrus® HD-OCT (Carl Zeiss, Jena, Germany)), and then routine examinations were performed. As described previously [24] , diagnostic criteria for glaucoma in the present study comprised glaucomatous visual field loss tested using the Glaucoma Hemifield Test, an ophthalmoscopic neurofiber layer defect, a cup/disc ratio > 0.6, or elevated IOP (> 21 mmHg) requiring topical medication for more than 6 months. We confirmed no change in glaucoma medication during study period with chart review.
Exclusion criteria were coexisting cataract with significant lens opacity disturbing the optical axis that accounted for subjective visual disturbance or decreased visual function, retinal pathology, retinal surgery, or photocoagulation affecting the visual field. Topical glaucoma medications were listed in Table S1 .
Statistical analysis
The effects of each season on the IOP were compared as follows. Based on a preliminary study and previous investigations suggesting that IOP is highest in winter and lowest in summer, we identified the mean IOP for each season and then compared summer and winter using by t-test or Mann-Whitney U test with Bonferroni correction to determine if the differences between seasons were significant. Mean IOP and the magnitude of seasonality among the four study groups were also compared. Regression analysis was performed to explore which parameters most affect the magnitude of seasonal difference in IOP. Ophthalmological parameters and glaucoma medications were analyzed with multiple regression from the first analysis since most cases were prescribed with PG as a baseline and beta blocker and CAI were often concomitantly prescribed.
Data are presented as the mean ± standard deviation (SD) or as percentages where appropriate. All analyses were performed using StatFlex (Atech, Osaka, Japan), with P < 0.05 considered significant.
Results
The characteristics, ophthalmological results and DED-related medications of 176 patients enrolled in this study (79 males and a mean age of 67.9 years) are detailed in Table 1 . The corneal staining score was higher in groups with short BUT compared with the control group. Non-glaucoma with short BUT group was prescribed more dry eye medications compared with the other groups; more than half (56%) of them received DED-related medications and 17-31% of patients in the other groups. Steroid eye-drops were used only for non-glaucoma groups. The distribution of seasons for BUT determination was similar in short and normal BUT groups (P=0.305 for non-glaucoma groups and P=0.118 for glaucoma groups, Mann-Whitney test) and there was a difference between glaucoma and non-glaucoma group (P=0.010, Kruskal Wallis test).
Prostaglandin analogues provided a first-line medication for 97.2% (70/72) of glaucoma patients and betablockers were prescribed for 25 cases (34.7%; Table S1 ). The mean number of eye-drops was 1.4 ± 0.7 for glaucoma without short BUT group and 1.2 ± 0.5 for glaucoma with short BUT group (P = 0.342, Kruskal Wallis test), and the mean frequency of instillation was 1.4 ± 1.0 for glaucoma without short BUT group and 1.7 ± 1.3 for glaucoma with short BUT group (P = 0.416). Monotherapy was administered for 28 cases (77.8%) of glaucoma without short BUT group and 27 cases (75.0%) of glaucoma with short BUT group. All of prescribed glaucoma medications contained benzalkonium chloride or other preservative; SofZiaR in TravatanzR and PolyquadR in DuotravR.
Mean IOP was significantly different between winter and summer in the short BUT groups (P < 0.001 for both glaucoma and non-glaucoma groups, paired t test), but not for the normal BUT groups (P = 0.964 for control group and P = 0.489 for glaucoma group)( Table 2 ). The mean magnitude of seasonality (winter-summer) was greater in short BUT groups than control, and it was largest in the glaucoma with short BUT. Comparison of IOP across seasons between glaucoma groups revealed significantly lower IOP in the short BUT group for all seasons except winter.
The individual range of IOP was smaller for the glaucoma groups than the non-glaucoma groups as indicated in minimum and maximum inter-individual variation across four seasons; 10 and 10 mmHg for glaucoma groups with and without short BUT, respectively, and 17 and 20 mmHg for non-glaucoma groups.
The graphic representation of the magnitude of seasonality are shown in Figures 1 and S1. Mean IOP value in each group presenting for IOP measurements was higher in winter than in summer.
Study groups with short tear break-up time (sB) showed larger fluctuation than those groups without sB. Linear regression analysis revealed that the magnitude of seasonality in IOP was correlated with BUT and the number and frequency of medication, whereas it was not correlated with age, sex, corneal staining score, mean deviation, refractive errors, and the type of medication (Table 3) . Multiple regression analysis demonstrated BUT was most strongly correlated with seasonality among three variables. Abbreviations: CAI, carbonic anhydrase inhibitor; NFL, thickness of peripapillary nerve fiber layer.
Discussion
The present results indicated the following two major findings: seasonality of IOP was greater with a short BUT compared to normal BUT, and IOP was lower with short BUT than with normal BUT. Based on the reported seasonal variation in DED, [7] the Schirmer test value was worst in winter, with BUT and corneal staining scores the second worst in winter for DED patients. In contrast, all of the corneal signs were less severe in summer. It is notable that seasonal variation in IOP in our study was similar to that reported for corneal staining score in a DED group described previously. [7] Corneal damage induce inflammation on the ocular surface leading to IOP increases mediated by bioactive molecules including TGF beta [26, 27] and prostaglandins. [28] Distress associated with uncomfortable symptoms including irritation, pain, and dryness could also raise IOP, particularly because depression is prevalent in DED patients and worsens in winter, and thus this state might result in ocular hypertension. [29] [30] [31] [32] Such an outcome might also explain the IOP reduction noted in summer when the corneal staining scores and DED symptoms are least severe. IOP and blood pressure are positively correlated and increased in winter, [13, 14] and adrenergic receptor activation has been conventionally proposed as a possible regulatory system for this phenomenon. [33] IOP fluctuations are generally differentiated in short-term (diurnal) and long-term IOP fluctuations (months -years) and the seasonal IOP fluctuation is the latter one. Our results suggested it could be present in both glaucoma and non-glaucoma cases.
The present results indicated that IOP was lower in cases with short BUT than in those with normal BUT, and this difference was larger between glaucoma groups than between non-glaucoma groups. Taken together, lower IOP values and larger winter IOP rises were predominantly observed in glaucoma cases with short BUT. This is paradoxical since if IOP increases with worsening of DED in the cold and dry weather of winter, IOP in short BUT should be higher than in normal BUT for all seasons. A possible explanation for this seeming anomaly is cornel thinning and drug penetration facilitated by disruption of the ocular surface barrier effects in DED as previous investigations suggested IOP may be estimated for lower value in thin cornea and intra-ocular drug effects of instilled eyedrop depend on drug penetration. [12, 34, 35] Sleep disorder, depression, and possible decreases in melatonin secretion could also contribute to the dysregulation of IOP[36] in winter when sunshine decreases and DED patients may suffer more stress and worsened symptoms.
Our study has several limitations. First, because this is an observational study, unmeasured or residual confounding factors may remain. Nonetheless, our multivariable adjusted analyses of major possible contributory factors should attenuate potential errors. Second, there is a fundamental limitation in the lack of data for corneal thickness and blood pressure because we failed to confirm whether thinner corneal thickness in DED including cases with short BUT and seasonal variation in blood pressure were directly attributed to the seasonal variation in IOP or other relevant neuronal factors such as use of neuronal or psychiatric medications in glaucoma cases. Therefore, future longitudinal studies with systemic evaluations of neuronal aspects are necessary to gain an understanding of seasonal IOP variation in glaucoma patients with short BUT. Third, because the majority of our participants were Japanese, our data may lack generalizability. Hence, additional studies performed in patients with different ethnicities are warranted to investigate the association between seasonality and BUT. Thus, we interpreted age-/sex-adjusted and multivariable-adjusted models in addition to univariable model results with some caution. Fourth, we should have used Goldmann tonometer as a gold standard for IOP measurement, however, we believe IOP data was obtained accurately enough for our study since most examinations were performed by certified orthoptists (national licensure) and we analyzed the mean IOP of three measurements. Finally, potential selection bias and heterogeneity among intergroups might not be completely eliminated, although the distribution of baseline characteristics for age and sex were reasonable in that more women were included in the short BUT groups and more myopic subjects were included in the glaucoma groups. Also, our study examined BUT once at the time of study entry and BUT values can vary among seasons on an individual basis. Thus, BUT and IOP could be measured in each season and a mixed effect model applied, although the distribution of the season for BUT measurement was uniformly distributed in the present study enabling us to address this issue.
This study has several strengths. First, this study was conducted in Japan with four distinct seasons presenting various temperature and humidity fluctuations. Second, the samples were collected from multiple institutions in Japan, allowing us to conduct a case-control study including enriched ophthalmic parameters in a rigorous manner. The novelty of our current study is that we successfully capture the distinctly enhanced seasonal variation in glaucoma patients accompanied with short BUT-type DED, with being very common and severely affecting quality of life through eye disease. Additionally, the present results were demonstrated as comparable with those of a large-scale study over 4000 cases to minimize a variety of bias.
[37] In a large-scale study we examined each patient once to immediately correlate IOP with DED, and the present study was carried out in a standard method with repeated examinations on the same patients to adequately analyze seasonal variation.
In conclusion, the eye care specialists should be careful of IOP in glaucoma cases with short BUT since seasonal IOP fluctuation may be greater than normal BUT cases and special attention should be paid for IOP rise in winter. BUT measurement could be recommended in glaucoma cases since any glaucoma medication may cause or aggravate DED and it could be associated with considerable IOP fluctuation. Funding: There is no funding for this study. Other A 0 4 A = Brimonidine tartrate for three and ripasudil hydrochloride hydrate for one. Abbreviations; BUT, tear break-up time; PG, prostaglandin analogue; CAI, carbonic anhydrase inhibitor. *P = 0.342, **P = 0.416 (Kruskal-Wallis).
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